Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Rank in Stocks #28133
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Share Price
$0.37430781
Last synced: 2026-08-19
Market Cap
$28.37M
Change (1 day)
2.00%
Change (1 year)
-13.46%
Country
CA
Trade Defence Therapeutics Inc. (DTC)

Category

Stock price history for Defence Therapeutics Inc. (DTC)
Highest end of day price: $0.32 on 2026-08-01

Lowest end of day price: $2.94 on 2021-05-01
Stock price history of Defence Therapeutics Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -20.25%
2025 47.28%
2024 -78.72%
2023 11.75%
2022 -62.63%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$123.27 -13.20%
AU
$753.28 5.84%
CH